Pulmatrix (NASDAQ: PULM) Investor Presentation 9/5/2018
Pulmatrix (NASDAQ: PULM) Investor Presentation 9/5/2018
VANCOUVER, Washington, June 24, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications today announced that […]
Discover Tomorrow’s Winning Stocks! Thank you for subscribing. Something went wrong. Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox. […]
Hoth Therapeutics, Inc. (NASDAQ: HOTH) will be a featured presenter at Wall Street Reporter’s Next Super Stock Live! online investor conference on September 25, 2019. Discover Tomorrow’s Winning Stocks! Thank you for subscribing. Something went wrong. […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
